MY135850A - Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use - Google Patents
Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their useInfo
- Publication number
- MY135850A MY135850A MYPI20032289A MYPI20032289A MY135850A MY 135850 A MY135850 A MY 135850A MY PI20032289 A MYPI20032289 A MY PI20032289A MY PI20032289 A MYPI20032289 A MY PI20032289A MY 135850 A MY135850 A MY 135850A
- Authority
- MY
- Malaysia
- Prior art keywords
- compounds
- medicaments
- preparation
- ring
- diphenylazetidinones
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 239000003814 drug Substances 0.000 title abstract 2
- VDOXIAUNJCHYRC-UHFFFAOYSA-N 1,3-diphenylazetidin-2-one Chemical class O=C1C(C=2C=CC=CC=2)CN1C1=CC=CC=C1 VDOXIAUNJCHYRC-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
ONE EMBODIMENT OF THE INVENTION RELATES TO COMPOUNDS OF THE FORMULA I, IN WHICH R1, R2, R3, R4, R5 AND R6 HAVE THE MEANINGS GIVEN IN THE SPECIFICATION.OTHER EMBODIMENTS OF THE INVENTION RELATE TO PHYSIOLOGICALLY ACCEPTABLE SALTS OF COMPOUNDS OF FORMULA I,TO PROCESSES FOR THEIR PREPARATION AND TO MEDICAMENTS COMPRISING THESE COMPOUNDS.THE COMPOUNDS OF THE INVENTION ARE SUITABLE FOR USE, FOR EXAMPLE,AS HYPOLIPIDEMICS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10227506A DE10227506A1 (en) | 2002-06-19 | 2002-06-19 | Ring-substituted diphenylazetidinones, processes for their preparation, pharmaceutical compositions containing them and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY135850A true MY135850A (en) | 2008-07-31 |
Family
ID=29719281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20032289A MY135850A (en) | 2002-06-19 | 2003-06-18 | Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP1517892B1 (en) |
| JP (1) | JP2005533072A (en) |
| CN (1) | CN1662493A (en) |
| AR (1) | AR039689A1 (en) |
| AT (1) | ATE478842T1 (en) |
| AU (1) | AU2003242616B2 (en) |
| BR (1) | BR0311940A (en) |
| CA (1) | CA2490109A1 (en) |
| DE (2) | DE10227506A1 (en) |
| EC (1) | ECSP045498A (en) |
| HN (1) | HN2003000183A (en) |
| HR (1) | HRP20041203A2 (en) |
| IL (1) | IL165791A0 (en) |
| MA (1) | MA27252A1 (en) |
| MX (1) | MXPA04012236A (en) |
| MY (1) | MY135850A (en) |
| NO (1) | NO20050073L (en) |
| NZ (1) | NZ537304A (en) |
| OA (1) | OA12868A (en) |
| PA (1) | PA8576001A1 (en) |
| PE (1) | PE20040577A1 (en) |
| PL (1) | PL372690A1 (en) |
| RS (1) | RS108504A (en) |
| RU (1) | RU2315754C2 (en) |
| SV (1) | SV2004001549A (en) |
| TN (1) | TNSN04255A1 (en) |
| TW (1) | TW200404774A (en) |
| UY (1) | UY27851A1 (en) |
| WO (1) | WO2004000804A1 (en) |
| ZA (1) | ZA200409381B (en) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0215579D0 (en) | 2002-07-05 | 2002-08-14 | Astrazeneca Ab | Chemical compounds |
| US7447226B2 (en) * | 2003-10-31 | 2008-11-04 | International Business Machines Corporation | Methods and apparatus for continuous connectivity between mobile device and network using dynamic connection spreading |
| WO2005061452A1 (en) | 2003-12-23 | 2005-07-07 | Astrazeneca Ab | Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity |
| CN101115726A (en) | 2004-12-03 | 2008-01-30 | 先灵公司 | Substituted piperazines as CB1 antagonists |
| WO2006107936A1 (en) * | 2005-04-04 | 2006-10-12 | Pontificia Universidad Catolica De Chile | The use of ezetimibe in the prevention and treatment of cholesterol gallstones |
| ATE450526T1 (en) | 2005-06-20 | 2009-12-15 | Schering Corp | PIPERIDINE DERIVATIVES SUITABLE AS ANTAGONISTS OF HISTAMINE H3 |
| SA06270191B1 (en) | 2005-06-22 | 2010-03-29 | استرازينيكا ايه بي | Novel 2-Azetidinone Derivatives as Cholesterol Absorption Inhibitors for the Treatment of Hyperlipidaemic Conditions |
| TW200811098A (en) | 2006-04-27 | 2008-03-01 | Astrazeneca Ab | Chemical compounds |
| BRPI0715160A2 (en) | 2006-08-08 | 2013-06-11 | Sanofi Aventis | arylamimoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, drugs comprising these compounds, and their use |
| BRPI0718052A2 (en) * | 2006-11-02 | 2015-06-16 | Sanofi Aventis Deutschland | Diphenylazotidinone substituted by piperazine-1 sulfonic acid and having improved pharmacological properties |
| DE102007002260A1 (en) | 2007-01-16 | 2008-07-31 | Sanofi-Aventis | Use of substituted pyranonic acid derivatives for the preparation of medicaments for the treatment of the metabolic syndrome |
| EP2025674A1 (en) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs |
| DE102007054497B3 (en) | 2007-11-13 | 2009-07-23 | Sanofi-Aventis Deutschland Gmbh | Novel crystalline diphenylazetidinone hydrates and process for their preparation |
| US8470841B2 (en) | 2008-07-09 | 2013-06-25 | Sanofi | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| WO2010100255A1 (en) | 2009-03-06 | 2010-09-10 | Lipideon Biotechnology Ag | Pharmaceutical hypocholesterolemic compositions |
| CN101993403B (en) | 2009-08-11 | 2012-07-11 | 浙江海正药业股份有限公司 | Azetidinone compound and medical applications thereof |
| ES2443016T3 (en) | 2009-08-26 | 2014-02-17 | Sanofi | New crystalline hydrates of heteroaromatic fluoroglycosides, pharmaceutical products comprising these compounds, and their use |
| EP2582709B1 (en) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
| EP2683705B1 (en) | 2011-03-08 | 2015-04-22 | Sanofi | Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| US8710050B2 (en) | 2011-03-08 | 2014-04-29 | Sanofi | Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| WO2012120052A1 (en) | 2011-03-08 | 2012-09-13 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
| EP2683704B1 (en) | 2011-03-08 | 2014-12-17 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5631365A (en) * | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| US5656624A (en) * | 1994-12-21 | 1997-08-12 | Schering Corporation | 4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents |
| CZ293957B6 (en) * | 1995-10-31 | 2004-08-18 | Scheringácorporation | Hypocholesterolemic sugar-substituted 2-azetidinones, pharmaceutical composition and a kit containing thereof |
| DE10042447A1 (en) * | 2000-08-29 | 2002-03-28 | Aventis Pharma Gmbh | Vertebrate intestinal protein that absorbs cholesterol and use of this protein to identify inhibitors of intestinal cholesterol transport |
-
2002
- 2002-06-19 DE DE10227506A patent/DE10227506A1/en not_active Withdrawn
-
2003
- 2003-01-17 HN HN2003000183A patent/HN2003000183A/en unknown
- 2003-06-02 SV SV2003001549A patent/SV2004001549A/en not_active Application Discontinuation
- 2003-06-04 JP JP2004514660A patent/JP2005533072A/en not_active Abandoned
- 2003-06-04 CN CN03814087XA patent/CN1662493A/en active Pending
- 2003-06-04 HR HR20041203A patent/HRP20041203A2/en not_active Application Discontinuation
- 2003-06-04 NZ NZ537304A patent/NZ537304A/en unknown
- 2003-06-04 EP EP03760591A patent/EP1517892B1/en not_active Expired - Lifetime
- 2003-06-04 RU RU2005101091/04A patent/RU2315754C2/en not_active IP Right Cessation
- 2003-06-04 CA CA002490109A patent/CA2490109A1/en not_active Abandoned
- 2003-06-04 WO PCT/EP2003/005815 patent/WO2004000804A1/en not_active Ceased
- 2003-06-04 DE DE50313017T patent/DE50313017D1/en not_active Expired - Lifetime
- 2003-06-04 OA OA1200400330A patent/OA12868A/en unknown
- 2003-06-04 AU AU2003242616A patent/AU2003242616B2/en not_active Ceased
- 2003-06-04 AT AT03760591T patent/ATE478842T1/en active
- 2003-06-04 BR BR0311940-8A patent/BR0311940A/en not_active IP Right Cessation
- 2003-06-04 PL PL03372690A patent/PL372690A1/en not_active Application Discontinuation
- 2003-06-04 RS YUP-1085/04A patent/RS108504A/en unknown
- 2003-06-04 MX MXPA04012236A patent/MXPA04012236A/en active IP Right Grant
- 2003-06-16 UY UY27851A patent/UY27851A1/en unknown
- 2003-06-17 AR ARP030102142A patent/AR039689A1/en unknown
- 2003-06-17 TW TW092116319A patent/TW200404774A/en unknown
- 2003-06-18 MY MYPI20032289A patent/MY135850A/en unknown
- 2003-06-18 PA PA20038576001A patent/PA8576001A1/en unknown
- 2003-06-18 PE PE2003000613A patent/PE20040577A1/en not_active Application Discontinuation
-
2004
- 2004-11-22 ZA ZA200409381A patent/ZA200409381B/en unknown
- 2004-12-08 MA MA27990A patent/MA27252A1/en unknown
- 2004-12-15 IL IL16579104A patent/IL165791A0/en unknown
- 2004-12-16 EC EC2004005498A patent/ECSP045498A/en unknown
- 2004-12-17 TN TNP2004000255A patent/TNSN04255A1/en unknown
-
2005
- 2005-01-06 NO NO20050073A patent/NO20050073L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005533072A (en) | 2005-11-04 |
| RS108504A (en) | 2007-02-05 |
| EP1517892A1 (en) | 2005-03-30 |
| HRP20041203A2 (en) | 2005-06-30 |
| EP1517892B1 (en) | 2010-08-25 |
| OA12868A (en) | 2006-09-15 |
| RU2005101091A (en) | 2005-07-10 |
| AR039689A1 (en) | 2005-03-09 |
| RU2315754C2 (en) | 2008-01-27 |
| TW200404774A (en) | 2004-04-01 |
| HN2003000183A (en) | 2003-08-01 |
| IL165791A0 (en) | 2006-01-15 |
| DE10227506A1 (en) | 2004-01-08 |
| TNSN04255A1 (en) | 2007-03-12 |
| CA2490109A1 (en) | 2003-12-31 |
| AU2003242616A1 (en) | 2004-01-06 |
| DE50313017D1 (en) | 2010-10-07 |
| ECSP045498A (en) | 2005-03-10 |
| MA27252A1 (en) | 2005-03-01 |
| CN1662493A (en) | 2005-08-31 |
| BR0311940A (en) | 2005-04-05 |
| NO20050073L (en) | 2005-01-06 |
| PA8576001A1 (en) | 2004-02-07 |
| MXPA04012236A (en) | 2005-02-25 |
| SV2004001549A (en) | 2004-03-19 |
| PE20040577A1 (en) | 2004-10-11 |
| ATE478842T1 (en) | 2010-09-15 |
| WO2004000804A1 (en) | 2003-12-31 |
| AU2003242616B2 (en) | 2008-12-11 |
| PL372690A1 (en) | 2005-07-25 |
| NZ537304A (en) | 2005-10-28 |
| UY27851A1 (en) | 2003-12-31 |
| ZA200409381B (en) | 2006-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY135850A (en) | Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use | |
| MY139302A (en) | Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof | |
| DE602004021472D1 (en) | Pyrimiidinverbindungen | |
| TW200610527A (en) | Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof | |
| TW200621777A (en) | New dihydropteridione derivatives, process for their manufacture and their use as medicament | |
| TW200801003A (en) | Novel compounds | |
| TW200621262A (en) | New dihydropteridione derivatives, process for their manufacture and their use as medicament | |
| MY139303A (en) | Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof | |
| SE0200920D0 (en) | Novel compounds | |
| TW200508214A (en) | Novel compounds | |
| AU2003228770A8 (en) | Substituted pyrazolopyrimidines | |
| SE0202539D0 (en) | Compounds | |
| EP1633740A4 (en) | Chemical compounds | |
| GEP20125565B (en) | Lactam compounds and their pharmaceutical use | |
| TW200500358A (en) | Compounds | |
| SE0302811D0 (en) | Novel compounds | |
| TW200800999A (en) | Novel compounds | |
| TW200616995A (en) | Novel compounds | |
| TW200613243A (en) | Novel compounds | |
| MX2010009022A (en) | 16 alpha, 17 alpa-acetal glucocorticosteroidal derivatives and their use. | |
| TW200833670A (en) | Novel compounds 569 | |
| SE0302139D0 (en) | Novel compounds | |
| TW200738659A (en) | Novel compounds | |
| ZA200409379B (en) | Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof | |
| SE0303541D0 (en) | New compounds |